To Evaluate The Safety and Efficacy of AVI Stent Comparing With Firebird2® For Treating Coronary Revascularization

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.

Also called NCT02133287

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,000 participants (planned count) (from the registry)
Sponsor
Beijing AmsinoMed Medical Device Co., Ltd (from the registry)
Registry
  • NCT NCT02133287
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02133287. Randomized; no masking; primary purpose treatment. Start 2013-08 (actual); primary completion 2018-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization
Condition
Ischemic Heart Disease
Condition
Myocardial Ischemia
Condition
Coronary Disease
Condition
Acute Coronary Syndrome
Intervention (Device)
AVI® Arsenic trioxide drug eluting stent delivery system
Intervention (Device)
Firebird2® sirolimus eluting stent system
Lead sponsor
Beijing AmsinoMed Medical Device Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct02133287
Content hash
03ef12488697becb1459d73ca50a577eae587b685b91539fb2a924930206b3b0